Inovio Pharmaceuticals, Inc. (INO)
NASDAQ · Healthcare
Inovio Pharmaceuticals, Inc. Shareholder Equity 2009–2025
Inovio Pharmaceuticals, Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Inovio Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: 24.1M, a 64.82% decrease year-over-year.
- Inovio Pharmaceuticals, Inc. shareholder equity for 2025 were 24.1M, a 64.82% decrease from 2024.
- Inovio Pharmaceuticals, Inc. shareholder equity for 2024 were 68.5M, a 41.62% decrease from 2023.
- Inovio Pharmaceuticals, Inc. shareholder equity for 2023 were 117.3M, a 47.23% decrease from 2022.
- Inovio Pharmaceuticals, Inc. shareholder equity for 2022 were 222.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inovio Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $24 |
| 2024 | $69 |
| 2023 | $117 |
| 2022 | $222 |
| 2021 | $400 |
| 2020 | $461 |
| 2019 | $3 |
| 2018 | $87 |
| 2017 | $142 |
| 2016 | $123 |
| 2015 | $176 |
| 2014 | $111 |
| 2013 | $52 |
| 2012 | $34 |
| 2011 | $47 |
Inovio Pharmaceuticals, Inc. Shareholder Equity — FAQ
Inovio Pharmaceuticals, Inc. (INO) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INO's shareholder equity history?
The chart and table above show Inovio Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.